Molecular Response After 3 Months of 1st Line Imatinib Therapy Is Predictive for Treatment Failure and Disease Progression In Patients with Chronic Phase Chronic Myeloid Leukemia - a Follow-up Analysis of the German CML Study IV
暂无分享,去创建一个
Martin C. Müller | H. Heimpel | S. Schnittger | D. Hossfeld | P. Erben | G. Ehninger | D. Heim | R. Hehlmann | A. Hochhaus | S. Krause | C. Nerl | G. Baerlocher | B. Hanfstein | A. Leitner | H. Kolb | H. Pralle | S. Saussele | U. Proetel